Skip to main content

transatlantic flight

The last time I took a transatlantic flight, I barely survived. I had to be carted off the plane by EMS personnel because I was too short of breath to walk even a few steps. Tomorrow I'm flying to England. Needless to say, I'm hoping this flight is uneventful. I'm relieved that my friend and colleague Carol is flying with me (we are presenting at the British Educational Research Association conference in Manchester). I wouldn't have felt comfortable making the trip by myself.

I will bring a heavy backup battery for my portable oxygen concentrator because airlines stipulate that you need enough battery power to last 1.5 times the flight duration. I'm not looking forward to having to wear the concentrator tube plus my glasses and a mask (too much COVID still going around) for the 7- to 8-hour flight -- lots of tubes, bands, and apparatuses on my ears, nose, and face.

I am grateful that my blood thinners are working and that my lungs have improved enough that I can once again fly across the ocean, albeit with some extra O2.  

Comments

  1. Clare HinrichsSeptember 6, 2024 at 8:14 PM

    May it be safe, uneventful travel-- and a great conference experience!

    ReplyDelete
  2. Dolores WarrenSeptember 6, 2024 at 9:00 PM

    Will be praying for a smooth healing flight !

    ReplyDelete
  3. AlisaSeptember 7, 2024 at 12:27 AM

    My dear all will be well with your health in the name of Jesus. It sounds like He has already done it. You are covered. You are absolutely right to wear your mask. You’ll recall we had Covid again in June. Safe travels & enjoy the conference 🩷

    ReplyDelete
  4. AlisaSeptember 7, 2024 at 12:28 AM

    And grab those compression stockings. I’m a fan!

    ReplyDelete
  5. AnonymousSeptember 7, 2024 at 12:47 AM

    Safe travels, Esther. So happy that you will be able to present in Manchester. It would be hassle to wear all that gear is only for the flight, but remember it is for your good health. I hope your conference goes well. Love ya. - Carolina

    ReplyDelete
  6. AnonymousSeptember 7, 2024 at 2:28 AM

    Good practice Esther for hopefully another one next year. Enjoy the trip, Mary

    ReplyDelete
  7. AnonymousSeptember 7, 2024 at 6:05 AM

    Amazing, Esther that you are headed out on this flight. It may be a pain to get there, but enjoy the trip. Big hugs, Henson

    ReplyDelete
  8. AnonymousSeptember 7, 2024 at 12:15 PM

    I admire how you are getting on with your life and not letting the memory of that last flight hold you back. You are so much stronger and wiser than you were then and everything will be fine.

    ReplyDelete
  9. Esther PrinsSeptember 7, 2024 at 2:40 PM

    Thank you! Doing my best to move on.

    ReplyDelete

Post a Comment

Popular posts from this blog

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...
10 comments
Read more

38.6 months

September 18 marked 38.6 months (3 years, 2 months, 18 days) since I first started taking Tagrisso. Why is 38.6 months significant? Because it is the median overall survival in the FLAURA study, a landmark study (2014-16) comparing Tagrisso and older targeted therapies among patients with advanced non-small cell lung cancer, EGFR mutation, and no prior treatment. 279 patients received Tagrisso and 277 people received an older drug (in addition, all patients received at least one dose of a trial drug). Nearly 58% of patients had died when data collection stopped. However, patients in the Tagrisso group lived nearly 7 months longer (median) than the control group. When Leland and I initially read that number – 38.6 months – in the Tagrisso promotional materials, we were stunned. This was supposed to be good news? The median age in the FLAURA study was 64 and at the time (August 2022), I had just turned 50. But still, it was a sobering statistic. For the longest time, I didn't feel ...
14 comments
Read more

A failure of institutional care

I just hit "send" on this letter to my dean and associate dean. Mic drop. I've never sent such a scathing letter, but it's definitely called for in this situation. I'm not expecting anything other than a "Oh, that wasn't how we intended to make you feel; our hands were tied" email. Dear Dean Lawless and Associate Dean Lloyd, When I wrote to Professor Land [my department head] to see if I could get a course release this fall due to having lung cancer plus complications from pulmonary embolism and COVID, I had no idea what I was in for. When faculty friends in other colleges have had health crises (ones that don’t warrant a full-semester medical leave), their department head or dean has simply said, “Don’t worry about teaching this semester. We’ll figure it out.” I figured the same would happen in my case. To be blunt, the way that my case was handled was a colossal failure of leadership. As my husband and I have shared my story with colleagues at PSU ...
26 comments
Read more